142 related articles for article (PubMed ID: 10697459)
1. [Adverse effects in short-term steroid therapy. Which adverse effects can be expected during daily administration of 20-40 mg prednisolone for a period 1-3 weeks?].
Jarlbaek L; Gram LF; Arnberg A
Ugeskr Laeger; 2000 Jan; 162(4):528-9. PubMed ID: 10697459
[No Abstract] [Full Text] [Related]
2. Malpractice claims regarding corticosteroids.
Falliers CJ
Arch Intern Med; 2003 May; 163(9):1112-3; author reply 1113. PubMed ID: 12742813
[No Abstract] [Full Text] [Related]
3. Randomized, double blind controlled trial of subcutaneous recombinant human interleukin-11 versus prednisolone in active Crohn's disease.
Herrlinger KR; Witthoeft T; Raedler A; Bokemeyer B; Krummenerl T; Schulzke JD; Boerner N; Kueppers B; Emmrich J; Mescheder A; Schwertschlag U; Shapiro M; Stange EF
Am J Gastroenterol; 2006 Apr; 101(4):793-7. PubMed ID: 16635225
[TBL] [Abstract][Full Text] [Related]
4. Systemic contact dermatitis to prednisone: a clinical model approach to the management of systemic allergy to corticosteroids.
De Benito V; Ratón JA; Palacios A; Garmendia M; Gardeazábal J
Clin Exp Dermatol; 2012 Aug; 37(6):680-1. PubMed ID: 22329833
[No Abstract] [Full Text] [Related]
5. [Posterior subcapsular cataract in a case of ulcerative colitis treated with corticosteroid enema].
Patteau F; Bourcier T; Naacke H; Allahdadi H; Borderie V; Laroche L
J Fr Ophtalmol; 2003 Oct; 26(8):834-6. PubMed ID: 14586226
[TBL] [Abstract][Full Text] [Related]
6. [Corticosteroid saving-up in giant cell arteritis?].
Schnabel A
Dtsch Med Wochenschr; 2002 Sep; 127(37):1910. PubMed ID: 12226792
[No Abstract] [Full Text] [Related]
7. Long-circulating liposomes for i.v. targeted delivery of glucocorticoids in arthritis.
Metselaar JM; Wauben MH; Boerman OC; Van Lent PL; Storm G
Cell Mol Biol Lett; 2002; 7(2):291-2. PubMed ID: 12097962
[No Abstract] [Full Text] [Related]
8. [The patient suffers from rheumatism for many years. It also makes the bones brittle].
MMW Fortschr Med; 2002 Oct; 144(41):57. PubMed ID: 12474369
[No Abstract] [Full Text] [Related]
9. [Chronic idiopathic thrombocytopenic purpura].
Treppendahl MB; Nielsen OJ
Ugeskr Laeger; 2004 Sep; 166(39):3389-93. PubMed ID: 15515391
[No Abstract] [Full Text] [Related]
10. [A case of cutaneous tuberculosis associated with steroid therapy for mixed connective tissue disease].
Yagi T; Yamagishi F; Mizutani F; Sasaki Y; Saitou M; Tada Y; Sakao S
Kekkaku; 1998 Sep; 73(9):557-62. PubMed ID: 9796208
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic issues in oral glucocorticoid use.
Bello CE; Garrett SD
Lippincotts Prim Care Pract; 1999; 3(3):333-41; quiz 342-4. PubMed ID: 10711134
[TBL] [Abstract][Full Text] [Related]
12. Resolved: Low-dose glucocorticoids are neither safe nor effective for the long-term treatment of rheumatoid arthritis.
Saag KG
Arthritis Rheum; 2001 Oct; 45(5):468-71. PubMed ID: 11642647
[No Abstract] [Full Text] [Related]
13. A comparative study of ocular side effects of pulse steroid therapy versus long-term oral steroid therapy in steroid responsiveness dermatoses.
Dogra A; Jain M; Bajwa GS; Aggarwal A
Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):213-4. PubMed ID: 12483972
[No Abstract] [Full Text] [Related]
14. Dermatitis following systemic prednisolone: patch testing with prednisolone eye drops.
Harris A; McFadden JP
Australas J Dermatol; 2000 May; 41(2):124-5. PubMed ID: 10812710
[TBL] [Abstract][Full Text] [Related]
15. Optimum management of glucocorticoid-treated patients.
Trikudanathan S; McMahon GT
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):262-71. PubMed ID: 18349823
[TBL] [Abstract][Full Text] [Related]
16. Fracture risk associated with systemic and topical corticosteroids.
Vestergaard P; Rejnmark L; Mosekilde L
J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
[TBL] [Abstract][Full Text] [Related]
17. Steroid-induced myopathy following a single oral dose of prednisolone.
Kumar S
Neurol India; 2003 Dec; 51(4):554-6. PubMed ID: 14742950
[TBL] [Abstract][Full Text] [Related]
18. [Dramatic deterioration after withdrawal of steroid therapy].
Stiefelhagen P
MMW Fortschr Med; 2006 May; 148(19):10. PubMed ID: 16736696
[No Abstract] [Full Text] [Related]
19. Glucocorticoids and joint destruction in rheumatoid arthritis.
Fries JF; Singh G
N Engl J Med; 1995 Dec; 333(23):1569; author reply 1570. PubMed ID: 7477183
[No Abstract] [Full Text] [Related]
20. Nasal steroid sprays and septal perforations.
Ferguson BJ
Ear Nose Throat J; 1997 Feb; 76(2):75-6. PubMed ID: 9046693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
